Teleflex Showcases New Clinical Data at Leading Urological Congresses Highlighting Patient Experience Advantages of the UroLift™ System and Long-Term Toxicity Reduction with Barrigel™ Rectal Space
Go back to Teleflex Showcases New Clinical Data at Leading Urological Congresses Highlighting Patient Experience Advantages of the UroLift™ System and Long-Term Toxicity Reduction with Barrigel™ Rectal Space| TELEFLEX INCORPORATED (NYSE: TFX) | Delayed: 127.00 +2.04 (1.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $124.96 | 52 Week High | $188.79 | |||
| Open | $125.50 | 52 Week Low | $125.28 | |||
| Day High | $127.30 | P/E | 36.71 | |||
| Day Low | $124.29 | EPS | $3.46 | |||
| Volume | 557,459 | |||||
